Literature DB >> 30114584

Personal care products use and phthalate exposure levels among pregnant women.

Chia-Jung Hsieh1, Yu-Hsun Chang2, Anren Hu3, Mei-Lien Chen4, Chien-Wen Sun5, Risanti Febrine Situmorang1, Ming-Tsang Wu6, Shu-Li Wang7.   

Abstract

BACKGROUND: Fetuses are susceptible to phthalates, known endocrine disrupting chemicals, within sensitive windows of development. It is crucial to determine the major sources of phthalates to reduce exposure. This study aims to examine the associations between usage patterns of personal care products (PCPs) and urinary levels of phthalate metabolites across pregnancy in a multi-hospital based birth cohort.
METHODS: During 2012-2015, we conducted a birth cohort study named the Taiwan Mother Infant Cohort Study (TMICS). Usage patterns of PCPs were obtained using structured questionnaires during the third trimester of pregnancy. Spot urine samples were collected at each trimester, and levels of eleven phthalate metabolites were measured by liquid chromatography tandem mass spectrometry. The association of PCPs use with urinary phthalate metabolite concentrations was assessed using GEE models.
RESULTS: Among the 1676 pregnant women participated in TMICS, 281 who provided two or three urine samples across pregnancy were included. The levels of several phthalate metabolites were significantly associated with the use of PCPs, particularly leave-on PCPs. With the increasing use of skin toners (11.7%; 95% CI: 1.5%, 22.9%), lipsticks (13.2%; 95% CI: 4.6%, 22.5%), and essential oils (21.8%; 95% CI: 9.1%, 36.0%), individuals are exposed to higher concentrations of mono-ethyl phthalate (MEP). Additionally, a positive trend was found regarding the number of leave-on PCPs used and the measured change in MEP concentrations (P for trend = 0.01). Other positive associations included MBzP and body lotions (7.9%; 95% CI: 0.1%, 16.2%). With regard to rinse-off PCPs, we found a positive association between urinary MBzP and shampoo use, and a negative association between urinary MMP and face wash.
CONCLUSION: Leave-on PCPs were found to be a more probable source of phthalate exposure than the use of rinse-off PCPs. We suggest pregnant women reduce the frequency of leave-on PCPs use during pregnancy to avoid such phthalate exposure.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Personal care product; Phthalate; Pregnancy; Repeated measurement; Urine

Mesh:

Substances:

Year:  2018        PMID: 30114584     DOI: 10.1016/j.scitotenv.2018.08.149

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  15 in total

1.  Association of self-reported personal care product use with blood glucose levels measured during pregnancy among women from a fertility clinic.

Authors:  Andrea Bellavia; Lidia Mínguez-Alarcón; Jennifer B Ford; Myra Keller; John Petrozza; Paige L Williams; Russ Hauser; Tamarra James-Todd
Journal:  Sci Total Environ       Date:  2019-08-09       Impact factor: 7.963

2.  Children's exposure to phthalates and non-phthalate plasticizers in the home: The TESIE study.

Authors:  Stephanie C Hammel; Jessica L Levasseur; Kate Hoffman; Allison L Phillips; Amelia M Lorenzo; Antonia M Calafat; Thomas F Webster; Heather M Stapleton
Journal:  Environ Int       Date:  2019-08-07       Impact factor: 9.621

3.  Identification of profiles and determinants of maternal pregnancy urinary biomarkers of phthalates and replacements in the Illinois Kids Development Study.

Authors:  Diana C Pacyga; Diana K Haggerty; Megan Nicol; Melissa Henning; Antonia M Calafat; Joseph M Braun; Susan L Schantz; Rita S Strakovsky
Journal:  Environ Int       Date:  2022-03-02       Impact factor: 9.621

Review 4.  Skin Changes and Safety Profile of Topical Products During Pregnancy.

Authors:  Imam Budi Putra; Nelva Karmila Jusuf; Nani Kumala Dewi
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

5.  Personal care products: Demographic characteristics and maternal hormones in pregnant women from Puerto Rico.

Authors:  Zorimar Rivera-Núñez; Pahriya Ashrap; Emily S Barrett; Adana A M Llanos; Deborah J Watkins; Amber L Cathey; Carmen M Vélez-Vega; Zaira Rosario; José F Cordero; Akram Alshawabkeh; John D Meeker
Journal:  Environ Res       Date:  2021-11-17       Impact factor: 6.498

6.  Urinary concentrations of phthalate metabolites during gestation and intrahepatic cholestasis of pregnancy: a population-based birth cohort study.

Authors:  Jian-Qing Wang; Hui Gao; Jie Sheng; Xing-Yong Tao; Kun Huang; Yun-Wei Zhang; Lei-Jing Mao; Shan-Shan Zhou; Zhong-Xiu Jin; Fang-Biao Tao
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-23       Impact factor: 4.223

7.  Socioeconomic and racial/ethnic differences in use of endocrine-disrupting chemical-associated personal care product categories among pregnant women.

Authors:  Emma V Preston; Marissa Chan; Katerina Nozhenko; Andrea Bellavia; Marissa C Grenon; David E Cantonwine; Thomas F McElrath; Tamarra James-Todd
Journal:  Environ Res       Date:  2021-05-03       Impact factor: 8.431

8.  Distribution and Dietary Predictors of Urinary Phthalate Metabolites among Pregnant Women in Shanghai, China.

Authors:  Xin He; Jiajie Zang; Ping Liao; Yang Zheng; Ye Lu; Zhenni Zhu; Yan Shi; Wenjing Wang
Journal:  Int J Environ Res Public Health       Date:  2019-04-16       Impact factor: 3.390

9.  Acculturation and endocrine disrupting chemical-associated personal care product use among US-based foreign-born Chinese women of reproductive age.

Authors:  Veronica A Wang; MyDzung T Chu; Lucy Chie; Symielle A Gaston; Chandra L Jackson; Nicole Newendorp; Elanah Uretsky; Robin E Dodson; Gary Adamkiewicz; Tamarra James-Todd
Journal:  J Expo Sci Environ Epidemiol       Date:  2020-11-24       Impact factor: 5.563

10.  Prenatal exposure to consumer product chemical mixtures and size for gestational age at delivery.

Authors:  P A Bommarito; B M Welch; A P Keil; G P Baker; D E Cantonwine; T F McElrath; K K Ferguson
Journal:  Environ Health       Date:  2021-06-10       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.